We are building an advanced AI platform, leveraging real world evidence, to pioneer the development of novel medicines for complex diseases. At its core, our technology integrates sophisticated predictors with variational autoencoders (VAEs). These VAEs have the remarkable ability to generate novel, safe, and effective therapies.
Our distinctive capability to prioritize drug design based on efficacy and safety before identifying specific ‘targets’ enables us to accelerate therapy development significantly, reducing both time and costs associated with drug discovery.
LatentSpace Therapeutics © Copyright 2024. All Rights Reserved.